Prognostic scoring models in parotid gland carcinoma.
follow-up
parotid gland carcinoma
prognosis
prognostic scoring model
recurrence risk
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
07 2021
07 2021
Historique:
revised:
28
01
2021
received:
28
09
2020
accepted:
27
02
2021
pubmed:
19
3
2021
medline:
2
7
2021
entrez:
18
3
2021
Statut:
ppublish
Résumé
The aim was to identify prognostic factors and test three prognostic scoring models that predicted the risk of recurrence in patients with parotid gland carcinoma. All Danish patients with parotid gland carcinoma, treated with curative intent, from 1990 to 2015 (n = 726) were included. Potential prognostic factors were evaluated using Cox regression and competing risk analyses. The concordance of each prognostic model was estimated using Harrel's C index. The study population consisted of 344 men and 382 women, with a median age of 63 years. Age above 60 years, high grade histology, T3/T4 tumor, regional lymph node metastases, and involved surgical margins were all associated with a significant reduction in recurrence-free survival. The prognostic model that agreed best with actual outcomes had a C-index of 0.76. Prognostic scoring models may improve individualized follow-up strategies after curatively intended treatment for patients with parotid gland carcinoma.
Sections du résumé
BACKGROUND
The aim was to identify prognostic factors and test three prognostic scoring models that predicted the risk of recurrence in patients with parotid gland carcinoma.
METHODS
All Danish patients with parotid gland carcinoma, treated with curative intent, from 1990 to 2015 (n = 726) were included. Potential prognostic factors were evaluated using Cox regression and competing risk analyses. The concordance of each prognostic model was estimated using Harrel's C index.
RESULTS
The study population consisted of 344 men and 382 women, with a median age of 63 years. Age above 60 years, high grade histology, T3/T4 tumor, regional lymph node metastases, and involved surgical margins were all associated with a significant reduction in recurrence-free survival. The prognostic model that agreed best with actual outcomes had a C-index of 0.76.
CONCLUSION
Prognostic scoring models may improve individualized follow-up strategies after curatively intended treatment for patients with parotid gland carcinoma.
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2081-2090Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Lima RA, Tavares MR, Dias FL, et al. Clinical prognostic factors in malignant parotid gland tumors. Otolaryngol Head Neck Surg. 2005;133(5):702-708.
Kane WJ, McCaffrey TV, Olsen KD, Lewis JE. Primary parotid malignancies. A clinical and pathologic review. Arch Otolaryngol Head Neck Surg. 1991;117(3):307-315.
Calearo C, Storchi OF, Pasture A, Polli G. Parotid gland carcinoma: analysis of prognostic factors. Ann Otol Rhinol Laryngol. 1998;107(11 Pt 1):969-973.
Eveson JW, Cawson RA. Salivary gland tumours. A review of 2410 cases with particular reference to histological types, site, age and sex distribution. J Pathol. 1985;146(1):51-58.
El-Nagger AK, Grandis JR, Takata T, Slootweg PJ. WHO Classification of Head and Neck Tumours. Lyon: International Agency for Research on Cancer (IARC); 2017.
Westergaard-Nielsen M, Godballe C, Eriksen JG, et al. Salivary gland carcinoma in Denmark: a national update and follow-up on incidence, histology, and outcome. Eur Arch Otorhinolaryngol. 2020;278(4):1179-1188. http://dx.doi.org/10.1007/s00405-020-06205-2.
Frankenthaler RA, Luna MA, Lee SS, et al. Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg. 1991;117(11):1251-1256.
Paderno A, Tomasoni M, Mattavelli D, Battocchio S, Lombardi D, Nicolai P. Primary parotid carcinoma: analysis of risk factors and validation of a prognostic index. Eur Arch Otorhinolaryngol. 2018;275(11):2829-2841.
Vander Poorten VL, Balm AJ, Hilgers FJ, et al. The development of a prognostic score for patients with parotid carcinoma. Cancer. 1999;85(9):2057-2067.
Carrillo JF, Vázquez R, Ramírez-Ortega MC, Cano A, Ochoa-Carrillo FJ, Oñate-Ocaña LF. Multivariate prediction of the probability of recurrence in patients with carcinoma of the parotid gland. Cancer. 2007;109(10):2043-2051.
Ali S, Palmer FL, Yu C, et al. A predictive nomogram for recurrence of carcinoma of the major salivary glands. JAMA Otolaryngol - Head Neck Surg. 2013;139(7):698-705.
Jegadeesh N, Liu Y, Prabhu RS, et al. Outcomes and prognostic factors in modern era management of major salivary gland cancer. Oral Oncol. 2015;51(8):770-777.
Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck. 2004;26(8):681-692.
Bjorndal K, Krogdahl A, Therkildsen MH, et al. Salivary gland carcinoma in Denmark 1990-2005: outcome and prognostic factors. Results of the Danish head and neck cancer group (DAHANCA). Oral Oncol. 2012;48(2):179-185.
Terhaard CH, van der Schroeff MP, van Schie K, et al. The prognostic role of comorbidity in salivary gland carcinoma. Cancer. 2008;113(7):1572-1579.
Stodulski D, Mikaszewski B, Stankiewicz C. Are all prognostic factors in parotid gland carcinoma well recognized? Eur Arch Otorhinolaryngol. 2012;269(3):1019-1025.
Lu CH, Liu CT, Chang PH, et al. Validation and comparison of the 7(th) edition of the American joint committee on cancer staging system and other prognostic models to predict relapse-free survival in Asian patients with parotid cancer. J Cancer. 2016;7(13):1833-1841.
Godballe C, Schultz JH, Krogdahl A, Moller-Grontved A, Johansen JJ. Parotid carcinoma: impact of clinical factors on prognosis in a histologically revised series. Laryngoscope. 2003;113(8):1411-1417.
Spiro RH, Armstrong J, Harrison L, Geller NL, Lin SY, Strong EW. Carcinoma of major salivary glands. Recent trends. Arch Otolaryngol Head Neck Surg. 1989;115(3):316-321.
Chang JW, Hong HJ, Ban MJ, et al. Prognostic factors and treatment outcomes of parotid gland cancer: a 10-year single-center experience. Otolaryngol Head Neck Surg. 2015;153(6):981-989.
Vander Poorten VL, Hart AA, van der Laan BF, et al. Prognostic index for patients with parotid carcinoma: external validation using the nationwide 1985-1994 Dutch head and neck oncology cooperative group database. Cancer. 2003;97(6):1453-1463.
Vander Poorten VL, Vauterin T, Jeunen G, et al. Prognostic index for patients with parotid carcinoma, international external validation in a Belgian-German database. Cancer. 2009;115(3):540-550.
Hay A, Migliacci J, Zanoni DK, et al. Validation of nomograms for overall survival, cancer-specific survival, and recurrence in carcinoma of the major salivary glands. Head Neck. 2018;40(5):1008-1015.
DAHANCA, Nationale retningslinier for udredning og behandling af spytkirtelkraeft i Danmark. 2018. https://www.dahanca.dk/uploads/TilFagfolk/Guideline/GUID_DAHANCA_spytkirtelkraeft_2019.pdf.
Takahama A Jr, Sanabria A, Benevides GM, de Almeida OP, Kowalski LP. Comparison of two prognostic scores for patients with parotid carcinoma. Head Neck. 2009;31(9):1188-1195.
Klussmann JP, Ponert T, Mueller RP, Dienes HP, Guntinas-Lichius O. Patterns of lymph node spread and its influence on outcome in resectable parotid cancer. Eur J Surg Oncol. 2008;34(8):932-937.
Ali S, Palmer FL, DiLorenzo M, Shah JP, Patel SG, Ganly I. Treatment of the neck in carcinoma of the parotid gland. Ann Surg Oncol. 2014;21(9):3042-3048.
Armstrong JG, Harrison LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer. 1992;69(3):615-619.
Frankenthaler RA, Byers RM, Luna MA, Callender DL, Wolf P, Goepfert H. Predicting occult lymph node metastasis in parotid cancer. Arch Otolaryngol - Head Neck Surg. 1993;119(5):517-520.
Lim YC, Lee SY, Kim K, et al. Conservative parotidectomy for the treatment of parotid cancers. Oral Oncol. 2005;41(10):1021-1027.
Shinomiya H, Otsuki N, Yamashita D, Nibu KI. Patterns of lymph node metastasis of parotid cancer. Auris Nasus Larynx. 2016;43(4):446-450.
Yoo SH, Roh JL, Kim SO, et al. Patterns and treatment of neck metastases in patients with salivary gland cancers. J Surg Oncol. 2015;111(8):1000-1006.
Zbaren P, Schüpbach J, Nuyens M, Stauffer E. Elective neck dissection versus observation in primary parotid carcinoma. Otolaryngol Head Neck Surg. 2005;132(3):387-391.
Qian K, Guo K, Zheng X, et al. The limited role of elective neck dissection in patients with cN0 salivary gland carcinoma. J Craniomaxillofac Surg. 2019;47(1):47-52.
Lau VH, Aouad R, Farwell DG, Donald PJ, Chen AM. Patterns of nodal involvement for clinically N0 salivary gland carcinoma: refining the role of elective neck irradiation. Head Neck. 2014;36(10):1435-1439.
van der Schroeff MP, Terhaard CHJ, Wieringa MH, Datema FR, Baatenburg de Jong RJ. Cytology and histology have limited added value in prognostic models for salivary gland carcinomas. Oral Oncol. 2010;46(9):662-666.
Kim YH, Chung WK, Jeong JU, et al. Evaluation of prognostic factors for the parotid cancer treated with surgery and postoperative radiotherapy. Clin Exp Otorhinolaryngol. 2019.